日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tamoxifen induces PI3K activation in uterine cancer.

他莫昔芬可诱导子宫癌细胞中PI3K活化。

Kübler Kirsten, Nardone Agostina, Anand Shankara, Gurevich Daniel, Gao Jianjiong, Droog Marjolein, Hermida-Prado Francisco, Akhshi Tara, Feiglin Ariel, Feit Avery S, Cohen Feit Gabriella, Dackus Gwen, Pun Matthew, Kuang Yanan, Cha Justin, Miller Mendy, Gregoricchio Sebastian, Lanfermeijer Mirthe, Cornelissen Sten, Gibson William J, Paweletz Cloud P, Van Allen Eliezer M, van Leeuwen Flora E, Nederlof Petra M, Nguyen Quang-Dé, Mourits Marian J E, Radovich Milan, Leshchiner Ignaty, Stewart Chip, Matulonis Ursula A, Zwart Wilbert, Maruvka Yosef E, Getz Gad, Jeselsohn Rinath

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

根据 BRCA1 状态评估年轻、淋巴结阴性、未接受化疗的三阴性乳腺癌患者的长期预后

Wang, Yuwei; Dackus, Gwen M H E; Rosenberg, Efraim H; Cornelissen, Sten; de Boo, Leonora W; Broeks, Annegien; Brugman, Wim; Chan, Terry W S; van Diest, Paul J; Hauptmann, Michael; Ter Hoeve, Natalie D; Isaeva, Olga I; de Jong, Vincent M T; Jóźwiak, Katarzyna; Kluin, Roelof J C; Kok, Marleen; Koop, Esther; Nederlof, Petra M; Opdam, Mark; Schouten, Philip C; Siesling, Sabine; van Steenis, Charlaine; Voogd, Adri C; Vreuls, Willem; Salgado, Roberto F; Linn, Sabine C; Schmidt, Marjanka K

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

组织病理学特征在未经化疗的三阴性乳腺癌患者中具有独立于间质肿瘤浸润淋巴细胞水平的预后价值

de Boo, L W; Jóźwiak, K; Ter Hoeve, N D; van Diest, P J; Opdam, M; Wang, Y; Schmidt, M K; de Jong, V; Kleiterp, S; Cornelissen, S; Baars, D; Koornstra, R H T; Kerver, E D; van Dalen, T; Bins, A D; Beeker, A; van den Heiligenberg, S M; de Jong, P C; Bakker, S D; Rietbroek, R C; Konings, I R; Blankenburgh, R; Bijlsma, R M; Imholz, A L T; Stathonikos, N; Vreuls, W; Sanders, J; Rosenberg, E H; Koop, E A; Varga, Z; van Deurzen, C H M; Mooyaart, A L; Córdoba, A; Groen, E; Bart, J; Willems, S M; Zolota, V; Wesseling, J; Sapino, A; Chmielik, E; Ryska, A; Broeks, A; Voogd, A C; van der Wall, E; Siesling, S; Salgado, R; Dackus, G M H E; Hauptmann, M; Kok, M; Linn, S C

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

间质肿瘤浸润淋巴细胞在未接受(新)辅助全身治疗的年轻、淋巴结阴性、三阴性乳腺癌患者中的预后价值

de Jong, Vincent M T; Wang, Yuwei; Ter Hoeve, Natalie D; Opdam, Mark; Stathonikos, Nikolas; Jóźwiak, Katarzyna; Hauptmann, Michael; Cornelissen, Sten; Vreuls, Willem; Rosenberg, Efraim H; Koop, Esther A; Varga, Zsuzsanna; van Deurzen, Carolien H M; Mooyaart, Antien L; Córdoba, Alicia; Groen, Emma J; Bart, Joost; Willems, Stefan M; Zolota, Vasiliki; Wesseling, Jelle; Sapino, Anna; Chmielik, Ewa; Ryska, Ales; Broeks, Annegien; Voogd, Adri C; Loi, Sherene; Michiels, Stefan; Sonke, Gabe S; van der Wall, Elsken; Siesling, Sabine; van Diest, Paul J; Schmidt, Marjanka K; Kok, Marleen; Dackus, Gwen M H E; Salgado, Roberto; Linn, Sabine C

Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images

基于深度学习的乳腺癌分级和全切片组织病理图像生存分析

Wetstein, Suzanne C; de Jong, Vincent M T; Stathonikos, Nikolas; Opdam, Mark; Dackus, Gwen M H E; Pluim, Josien P W; van Diest, Paul J; Veta, Mitko

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients

围绝经期乳腺癌患者化疗后辅助使用芳香化酶抑制剂或他莫昔芬

Dackus, Gwen M H E; Jóźwiak, Katarzyna; Sonke, Gabe S; van der Wall, Elsken; van Diest, Paul J; Siesling, Sabine; Hauptmann, Michael; Linn, Sabine C

A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer

一项针对晚期癌症患者的 I 期剂量递增研究,评估了两个周期卡铂-奥拉帕尼联合化疗后序贯奥拉帕尼单药治疗的效果。

Geenen, Jill J J; Dackus, Gwen M H E; Schouten, Philip C; Pluim, Dick; Marchetti, Serena; Sonke, Gabe S; Jóźwiak, Katarzyna; Huitema, Alwin D R; Beijnen, Jos H; Schellens, Jan H M; Linn, Sabine C

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer

早期HER2阳性乳腺癌中曲妥珠单抗与化疗同时使用与序贯使用

Dackus, Gwen M H E; Jóźwiak, Katarzyna; van der Wall, Elsken; van Diest, Paul J; Hauptmann, Michael; Siesling, Sabine; Sonke, Gabe S; Linn, Sabine C

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study

未接受辅助全身治疗的年轻乳腺癌患者(≤40岁)的长期预后:PARADIGM计划队列研究方案

Dackus, Gwen Mhe; Ter Hoeve, Natalie D; Opdam, Mark; Vreuls, Willem; Varga, Zsuzsanna; Koop, Esther; Willems, Stefan M; Van Deurzen, Carolien Hm; Groen, Emilie J; Cordoba, Alicia; Bart, Jos; Mooyaart, Antien L; van den Tweel, Jan G; Zolota, Vicky; Wesseling, Jelle; Sapino, Anna; Chmielik, Ewa; Ryska, Ales; Amant, Frederic; Broeks, Annegien; Kerkhoven, Ron; Stathonikos, Nikolas; Veta, Mitko; Voogd, Adri; Jozwiak, Katarzyna; Hauptmann, Michael; Hoogstraat, Marlous; Schmidt, Marjanka K; Sonke, Gabe; van der Wall, Elsken; Siesling, Sabine; van Diest, Paul J; Linn, Sabine C

Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors

雌激素受体 α 在形态相似的子宫内膜肿瘤之间发挥治疗特异性增强剂的作用

Marjolein Droog, Ekaterina Nevedomskaya, Gwen M Dackus, Renske Fles, Yongsoo Kim, Harry Hollema, Marian J Mourits, Petra M Nederlof, Hester H van Boven, Sabine C Linn, Flora E van Leeuwen, Lodewyk F A Wessels, Wilbert Zwart